ARRY Faces Index Deletions and Target Cuts as Stock Hits New Lows

Short positioning compounds the picture. Bears have built a substantial stake: short interest is 25.2% of the free float, up 30% over the past month as the stock has declined. The borrow market is essentially drained. Availability has dropped to zero percent, a level it has held since mid-September, meaning every share in the lending pool is currently lent out. Despite that tightness, borrowing is cheap at 0.85% annually, suggesting the demand surge was absorbed without spiking rates, and the short score of 74.4 puts the stock in the 2nd percentile for its short-score rank, one of the most heavily flagged names in the ORTEX universe. Options traders have not leaned defensively: the put/call ratio is 0.18, well below its 20-day average of 0.22 and near the 52-week low of 0.16. That combination of heavy short interest and light put demand is unusual. It implies that bearish pressure is expressed through the stock lending market rather than through the options market.

A structural selling catalyst may add to near-term pressure. ORTEX forecasts a 95% probability that ARRY is deleted from the CRSP US Small Cap index at the December 2026 quarterly review, which would require index trackers to sell approximately $8 million worth of shares, around 0.3 days of normal volume, with the trade date on December 22. The stock would need to close above $5.50 to escape the deletion, a price 54% above the current level. ORTEX also puts a 46% probability on deletions from three MSCI small-cap benchmarks at the November 2026 review, with announcement due November 11 and a combined forced-selling flow of roughly $40 million to $60 million across those indices. None of these are confirmed; they are forecasts, not announcements. But the directional weight is clear.

The Q2 print in August set a grim recent precedent. The stock fell 12.6% the day results were released and extended that to a 13.6% loss over the following five sessions. The next earnings event is scheduled for November 5, leaving about three weeks before investors get an updated read on revenue trajectory and margins. The bull case, last formalised in October 2025, rested on recovering revenue growth and multiple expansion from 11x to 13x EBITDA. The bear case centres on solar demand softening, margin erosion from non-US business, and limited direct customer relationships. At a trailing PE of 4x and EV/EBITDA of 6.2x, the stock is not expensive in isolation, but the EPS surprise factor score of 16 out of 100 suggests the company has a recent history of disappointing relative to expectations.

The November 5 earnings date, the November 11 MSCI announcement window, and the December CRSP rank date form the next sequence of catalysts worth tracking.